12 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 12 of 12 clinical reviews.
A clinician-reviewed guide to how vardenafil affects adolescent development, covering physiology, FDA approval status, safety data, and the rare pediatric conditions where it is studied.
What adolescents aged 12-17 taking vardenafil need to know about school, sports, and daily activities: side effects that affect the classroom, physical activity restrictions, disclosure guidance, and safety protocols.
A clinician-reviewed guide covering how older adults aged 65 and above can use vardenafil (Levitra/Staxyn) safely while staying active, social, and engaged in educational or community settings.
A clinician-reviewed guide to transitioning adolescents ages 12-17 from pediatric to adult care when vardenafil is part of their treatment plan, covering dosing, safety monitoring, consent, and care coordination.
How age-related physiology changes vardenafil pharmacokinetics, efficacy, and safety in men 65 and older. Evidence-based dosing, drug interactions, and clinical guidance for geriatric patients on Levitra or Staxyn.
A physician-reviewed guide to vardenafil use in patients aged 65 and older, covering off-label indications, age-adjusted dosing, drug interactions, and the clinical evidence behind geriatric prescribing decisions.
A clinician-reviewed guide to vardenafil dosing, safety, drug interactions, and monitoring for patients aged 65 and older transitioning from general adult to geriatric erectile dysfunction care.
A clinical overview of vardenafil's off-label use in pediatric patients under age 12, covering pulmonary arterial hypertension, safety data, dosing considerations, and regulatory status. Reviewed by the HealthRX medical team.
A clinical guide to managing vardenafil use in pediatric patients under age 12 with pulmonary arterial hypertension, covering safety evidence, off-label prescribing rationale, and the structured transition to adult care settings.
A clinically rigorous review of vardenafil off-label use in adolescents aged 12 to 17, covering approved indications, pediatric pharmacokinetics, pulmonary hypertension evidence, safety signals, and prescribing guidance.
A clinical reference on vardenafil's pharmacology, safety signals, and developmental risks in children under 12, reviewed by the HealthRX medical team.
A clinical guide for caregivers and prescribers on managing vardenafil use in children under 12, covering school administration, physical activity restrictions, side-effect monitoring, and coordination with educational staff.